论文部分内容阅读
在新医改的推动下,医药流通行业正处于一场急剧整合的漩涡中,或将催生这一领域的“苏宁和国美”。在新医改倡导以省为单位的配送政策、以及药品限价等政策的催热下,加之商务部接管医药流通业后,强力助推行业兼并整合。整个医药流通行业正处于一场急剧整合的漩涡中。基于新医改的推动,医药流通商们已经开始在酝酿新的商业模式,未来有望催生医药流通业里的苏宁、国美。
Driven by the new health care reform, the pharmaceutical circulation industry is in the midst of a spiral of sharp integration and will lead to the emergence of “Suning and Gome” in this area. In the new medical reform advocated by the provincial unit of the distribution policy, as well as drug prices and other policies under the urging, combined with the Ministry of Commerce took over the pharmaceutical distribution industry, strongly boost the industry mergers and acquisitions. The entire pharmaceutical distribution industry is in a sharp spiral of consolidation. Based on the promotion of new medical reform, pharmaceutical distributors have already started to brew new business models and the future is expected to spawn Suning and Gome in the pharmaceutical distribution industry.